News

benzinga_article
2025.11.17 13:02
Autonomix Medical shares are trading higher after the company reported post-hoc subgroup analysis results from its first-in-human study showing potential quality-of-life improvements with its targeted ablation therapy.
Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.